BRPI0913337A2 - liberação pulsátil de valsartan - Google Patents
liberação pulsátil de valsartanInfo
- Publication number
- BRPI0913337A2 BRPI0913337A2 BRPI0913337A BRPI0913337A BRPI0913337A2 BR PI0913337 A2 BRPI0913337 A2 BR PI0913337A2 BR PI0913337 A BRPI0913337 A BR PI0913337A BR PI0913337 A BRPI0913337 A BR PI0913337A BR PI0913337 A2 BRPI0913337 A2 BR PI0913337A2
- Authority
- BR
- Brazil
- Prior art keywords
- valsartan
- pulsatile release
- pulsatile
- release
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5823308P | 2008-06-03 | 2008-06-03 | |
| PCT/US2009/045786 WO2009148990A1 (en) | 2008-06-03 | 2009-06-01 | Pulsatile release of valsartan |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0913337A2 true BRPI0913337A2 (pt) | 2017-05-23 |
Family
ID=40974663
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0913337A BRPI0913337A2 (pt) | 2008-06-03 | 2009-06-01 | liberação pulsátil de valsartan |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20110189286A1 (pt) |
| EP (1) | EP2285358A1 (pt) |
| JP (1) | JP2011522050A (pt) |
| KR (1) | KR20110015650A (pt) |
| CN (1) | CN102046154A (pt) |
| AU (1) | AU2009256423A1 (pt) |
| BR (1) | BRPI0913337A2 (pt) |
| CA (1) | CA2726793A1 (pt) |
| MX (1) | MX2010013238A (pt) |
| WO (1) | WO2009148990A1 (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102028659A (zh) * | 2010-12-16 | 2011-04-27 | 苏州大学 | 一种缬沙坦生物粘附性包衣微丸制剂及其制备方法 |
| CN102133197B (zh) * | 2011-03-18 | 2012-06-27 | 海南美兰史克制药有限公司 | 一种缬沙坦脂微球固体制剂 |
| CN102626395B (zh) * | 2012-04-19 | 2014-02-26 | 海南美兰史克制药有限公司 | 一种阿利克仑缬沙坦药物组合物脂质体固体制剂 |
| KR101269829B1 (ko) * | 2012-04-27 | 2013-05-30 | 씨제이제일제당 (주) | 위체류 약물전달 시스템을 이용한 서방성 제제 |
| CN102641253B (zh) * | 2012-05-07 | 2013-10-09 | 山东省医药工业研究所 | 缬沙坦缓释片及其制备方法 |
| CA2888135A1 (en) * | 2012-10-14 | 2014-04-17 | The Board Of Regents, The University Of Texas System | Delivery of small interfering rna and micro rna through membrane-disruptive, responsive nanoscale hydrogels |
| KR102237799B1 (ko) | 2012-11-14 | 2021-04-08 | 더블유.알. 그레이스 앤드 캄파니-콘. | 생물학적 활성 물질 및 비-정렬된 무기 산화물을 함유하는 조성물 |
| EP3041463A1 (en) | 2013-09-02 | 2016-07-13 | Sun Pharmaceutical Industries Ltd | Pulsatile-release dosage form |
| WO2018002673A1 (en) * | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
| KR101920628B1 (ko) * | 2017-04-12 | 2018-11-22 | 대원제약주식회사 | 안지오텐신 수용체 길항제를 포함하는 약제학적 조성물 |
| CN113133978B (zh) * | 2020-01-20 | 2023-10-17 | 鲁南制药集团股份有限公司 | 一种阿齐沙坦片及其制备方法 |
| KR20220091767A (ko) * | 2020-12-24 | 2022-07-01 | 주식회사 보령 | 사쿠비트릴 발사르탄 하이브리드 화합물 또는 그 약제학적으로 허용되는 염을 유효성분으로 포함하는 약제학적 조성물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006113631A2 (en) * | 2005-04-18 | 2006-10-26 | Rubicon Research Pvt. Ltd. | Bioenhanced compositions |
| PE20080907A1 (es) * | 2006-08-31 | 2008-08-22 | Novartis Ag | Sistema de suministro de farmaco oral gastro-retentivo de liberacion extendida para valsartan |
| WO2008064338A2 (en) * | 2006-11-22 | 2008-05-29 | Rubicon Research Pvt. Ltd. | Valsartan formulation for pulsatile delivery |
| WO2008084504A2 (en) * | 2007-01-12 | 2008-07-17 | Rubicon Research Private Limited | Pharmaceutical compositions of angiotensin ii receptor blockers |
| JP2010534721A (ja) * | 2007-07-27 | 2010-11-11 | ディポメド，インコーポレイティド | パルス型胃滞留性製剤 |
-
2009
- 2009-06-01 CN CN2009801204840A patent/CN102046154A/zh active Pending
- 2009-06-01 AU AU2009256423A patent/AU2009256423A1/en not_active Abandoned
- 2009-06-01 MX MX2010013238A patent/MX2010013238A/es not_active Application Discontinuation
- 2009-06-01 BR BRPI0913337A patent/BRPI0913337A2/pt not_active IP Right Cessation
- 2009-06-01 EP EP09759151A patent/EP2285358A1/en not_active Withdrawn
- 2009-06-01 US US12/995,577 patent/US20110189286A1/en not_active Abandoned
- 2009-06-01 WO PCT/US2009/045786 patent/WO2009148990A1/en active Application Filing
- 2009-06-01 CA CA2726793A patent/CA2726793A1/en not_active Abandoned
- 2009-06-01 JP JP2011512556A patent/JP2011522050A/ja active Pending
- 2009-06-01 KR KR1020107029694A patent/KR20110015650A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011522050A (ja) | 2011-07-28 |
| MX2010013238A (es) | 2010-12-21 |
| CN102046154A (zh) | 2011-05-04 |
| AU2009256423A1 (en) | 2009-12-10 |
| US20110189286A1 (en) | 2011-08-04 |
| KR20110015650A (ko) | 2011-02-16 |
| CA2726793A1 (en) | 2009-12-10 |
| WO2009148990A1 (en) | 2009-12-10 |
| EP2285358A1 (en) | 2011-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0913337A2 (pt) | liberação pulsátil de valsartan | |
| BRPI1013622A2 (pt) | cápsula liberadora | |
| GB2473392B (en) | Methods of diagnosis | |
| BRPI0914630A2 (pt) | liberação dérmica | |
| DE602009000580D1 (de) | Endoskopsystem | |
| BRPI0918249A2 (pt) | prótese | |
| ZA201102604B (en) | Alkylcyclohexylethers of dihydrotetraazabenzoazulenes | |
| DE112010001657A5 (de) | Kupplungsparameter | |
| BR112012002271A2 (pt) | cápsulas de liberação sustentada | |
| PL2133419T3 (pl) | Zastosowania beta-dipeptydów cyjanoficyny | |
| DE112009002641A5 (de) | Klemmkörperfreilauf | |
| HK1160925A1 (zh) | 組織蛋白酶 的用途 | |
| FI20096402A0 (fi) | Veriryhmästatuksen käyttö II | |
| DE112010001788A5 (de) | Kupplung | |
| DK2173197T3 (da) | Fremgangsmåde | |
| CU23884B1 (es) | Derivados de dibenzotiazepina | |
| BRPI0920833A2 (pt) | preparação de benzonorborbenos | |
| DE112009002440A5 (de) | Kupplung | |
| BRPI0913967A2 (pt) | freio | |
| DE502008003154D1 (de) | Notentriegelung | |
| FR2929506B1 (fr) | Orthese de contention | |
| SE0900379L (sv) | Benstöd | |
| BRPI0922008A2 (pt) | compostos e respectivos metodos de preparação | |
| EP2331490A4 (en) | PREPARATION OF DIBUTOXYMETHANE | |
| IT1391542B1 (it) | Cassaforte |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: application dismissed [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |